Celltrion Healthcare Co., Ltd. (KOSDAQ:A091990) announces a share repurchase program. Under the program, the company will repurchase up to 690,000 shares. The purpose of the share repurchase program is to stabilize the share price and enhance shareholder value.

The repurchase program will continue until November 28, 2023. As of August 27, 2023, the company had 4,068,854 shares in treasury within scope available for dividend and had 382,497 shares in treasury through other acquisition.